BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32495876)

  • 1. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma.
    Qiu ML; Li X; Lin JB; Luo RG; Liu B; Feng Z
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5412-5418. PubMed ID: 32495876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum exosomal microRNA-766-3p expression is associated with poor prognosis of esophageal squamous cell carcinoma.
    Liu S; Lin Z; Zheng Z; Rao W; Lin Y; Chen H; Xie Q; Chen Y; Hu Z
    Cancer Sci; 2020 Oct; 111(10):3881-3892. PubMed ID: 32589328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
    Tanaka Y; Kamohara H; Kinoshita K; Kurashige J; Ishimoto T; Iwatsuki M; Watanabe M; Baba H
    Cancer; 2013 Mar; 119(6):1159-67. PubMed ID: 23224754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma.
    Xiao Z; Feng X; Zhou Y; Li P; Luo J; Zhang W; Zhou J; Zhao J; Wang D; Wang Y; Tian Z; Zhao X
    Int J Nanomedicine; 2023; 18():95-114. PubMed ID: 36636641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression.
    He Z; Li W; Zheng T; Liu D; Zhao S
    J Exp Clin Cancer Res; 2020 Jul; 39(1):140. PubMed ID: 32698859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Zheng S; Zhang X; Wang X; Li J
    Cancer Biomark; 2017 Jul; 20(1):49-54. PubMed ID: 28759955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
    Zhang N; Zhang PP; Huang JJ; Wang ZY; Zhang ZH; Yuan JZ; Ma EM; Liu X; Bai J
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived exosomal miR-103a-2-5p facilitates esophageal squamous cell carcinoma cell proliferation and migration.
    Gao DC; Hou B; Zhou D; Liu QX; Zhang K; Lu X; Zhang J; Zheng H; Dai JG
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6097-6110. PubMed ID: 32572925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
    Zhang Y; Xu H
    J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
    Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
    Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
    Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.
    Takeshita N; Hoshino I; Mori M; Akutsu Y; Hanari N; Yoneyama Y; Ikeda N; Isozaki Y; Maruyama T; Akanuma N; Komatsu A; Jitsukawa M; Matsubara H
    Br J Cancer; 2013 Feb; 108(3):644-52. PubMed ID: 23361059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
    Wu C; Li M; Hu C; Duan H
    Mol Biol Rep; 2014 Mar; 41(3):1257-66. PubMed ID: 24390317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.
    Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H
    Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
    Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
    Liu W; Liu J; Zhang Q; Wei L
    Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.